Dai-ichi Life invests in Covid-19 vaccine bond

Japanese insurance company Dai-ichi Life has invested JPY15.8 billion ($147 million) into a vaccine bond, issued by the International Finance Facility for Immunisation (IFFIm).

To access this article please sign-in below or register for a free one-month trial.

Login
Forgot your password?

To access the premium content on Environmental Finance, you must first sign in to your account

Not registered? Take a free no obligation one-month trial.

Register for a trial